AzTrials
AzTrials

Coronary Artery DiseaseJBTinCBLNCT02167230

Jailed-balloon Technique in Coronary Bifurcation Lesion PCI

A study testing Jailed-balloon technique and Jailed-wire technique in people with Coronary Artery Disease, run by Guangdong Provincial People's Hospital at 2 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to test the hypothesis that jailed-balloon technique(JBT) is superior to jailed-wire technique(JWT) in non-left main coronary bifurcation percutaneous coronary intervention(PCI) by lowering the risk of side branch(SB) loss and PCI related myocardial infarction, as well as 1-year major adverse… Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Coronary Artery Disease
What is being tested?
Jailed-balloon technique and Jailed-wire technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
410 participants
Where
2 sitesChina
Study dates
Oct 2014to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years and ≤75 years;
  • De novo Medina 1,1,1 coronary bifurcation with a main branch(MB) >2.5mm while side branch <2.5mm and >1.5mm;
  • Only one bifurcation lesion need to be treated in one vessel;
  • The target lesion in MB has stenosis more than 75% or fractional flow reserve(FFR) less than 0.75 and the stenosis in SB ostium is more than 50%;
  • Signed consent is obtained.

Who cannot join

  • Left ventricular ejection fraction(LVEF) less than 30%;
  • Hemodynamic instability or cardiac shock;
  • Myopathy or muscular injury with elevation of creatine kinase to more than 3mg/dL;
  • Tumor with expected survival less than 1 year;
  • Autoimmune disease;
  • Active gastrointestinal bleeding or any contraindication for dual antiplatelet therapy;
Show all 13Show fewer
  • Acute coronary syndrome require emergency PCI;
  • Coronary bifurcation need to be treated with two-stent strategy;
  • Not suitable for drug-eluting stent(DES) implantation;
  • Mental disorder or alcohol dependence;
  • PCI or coronary artery bypass graft (CABG) within 6 months before enrollment;
  • Target lesion is in-stent restenosis;
  • Women in gestation period or lactation period or human chorionic gonadotropin (HCG) urine test positive.

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Kashgar District 1st People's Hospital

    Kashgar, Xinjiang, 844000

    Heyin Yang, Bachelor, 86-998-2565206, 13579068456@163.com

    Yuying Hu, Bachelor, 86-998-2565208, huyuyingks@163.com

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, 518020

    Shaohong Dong, Doctor, 86-755-25533018 ext. 3221, dsh266@medmail.com

    Huadong Liu, Doctor, 86-755-25533018 ext. 3202, lhd2578@163.com

Other trials in China

About this study

Official title: Effect of Jailed-Balloon Technique in Percutaneous Coronary Intervention for Non-Left Main Coronary Bifurcation Lesions: A Prospective, Randomized Study.

This study aims to test the hypothesis that jailed-balloon technique(JBT) is superior to jailed-wire technique(JWT) in non-left main coronary bifurcation percutaneous coronary intervention(PCI) by lowering the risk of side branch(SB) loss and PCI related myocardial infarction, as well as 1-year major adverse cardiovascular events(MACEs).

Read the detailed description
  1. Objective: To compare the protective effect between JBT and JWT during PCI for non-left main coronary bifurcation lesions.
  2. Background: Solid evidence is scant to compare the protective effect between JBT and JWT during PCI for non-left main coronary bifurcation lesions.
  3. Study design: This is a multi-center, prospective, randomized study.
  4. Methods

4a. Study populations: Patients with non-left main coronary bifurcation lesions(Medina 1,1,1 ), which SBs are less than 2.5mm and more than 1mm, are enrolled in this study. Patients are randomized to JBT group and JWT group.

4b. Procedure: For patients enrolled in JBT group, a monorail balloon is placed at the ostium of SB to protect the SB before the stent in main branch(MB) is deployed. Only a PTCA wire would be placed in the SB while stenting MB for patients randomized in JWT group. Only drug-eluting stent should be implanted in the target vessel.

Being tested
Jailed-balloon technique, Jailed-wire technique
Keywords
Coronary Artery Disease, Percutaneous Coronary Intervention, Bifurcation, Jailed-balloon technique
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jailed-balloon techniqueProcedure or surgery

    A monorail balloon is placed in the side branch(SB) before the stent in main branch(MB) is deployed. After MB stent is deployed to nominal pressure, the balloon in SB is inflated to 3 atm generally but to higher pressure to perform angioplasty if the blood flow in SB is compromised. The balloon in SB is then removed while the wire in SB is left in place. The MB stent balloon is inflated again for stent apposition. The SB wire is left in place to facilitate rewiring if the blood flow in SB is compromised. Otherwise the SB wire is removed after the stent balloon is inflated again.

  • Jailed-wire techniqueProcedure or surgery

    A percutaneous transluminal coronary angioplasty(PTCA) wire is placed in the side branch(SB) before the stent in main branch(MB) is deployed. After MB stent is deployed to some pressure to achieve full apposition, the wire in SB is left in place to facilitate rewiring if the blood flow in SB is compromised. Otherwise the SB wire is removed after the MB stent is deployed.

Study groups in NCT02167230
Study groupRoleWhat they receive
Jailed-balloon techniqueExperimentalApply jailed-balloon technique to protect the side branch during coronary bifurcation PCI
Receives: Procedure: Jailed-balloon technique
Jailed-wire techniqueActive comparatorApply jailed-wire technique to protect the side branch during coronary bifurcation PCI
Receives: Procedure: Jailed-wire technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Side branch(SB) loss and PCI related myocardial infarction

    The primary outcome of the study is a composite of SB loss or PCI related myocardial infarction.

    According to Thrombolysis in Myocardial Infarction (TIMI) flow grading system, SB loss is defined as less than TIMI 3 flow immediately following MB stenting. It is considered temporary SB loss if TIMI 3 flow is restored with angioplasty and/or stenting. Otherwise, SB loss is considered permanent.

    In patients with normal (≤99th percentile URL) baseline cardiac troponin(cTn) concentrations, PCI related myocardial infarction is defined as elevations of cTn >5× 99th percentile URL occurring within 48 hours of the procedure, which should be accompanied with other evidence of myocardial injury. A rise of >20% is required for the diagnosis of PCI related myocardial infarction if the baseline cTn values are elevated and are stable or falling.

    Measured: Within 48 hours after PCI

Secondary outcomes (2)
  1. Major adverse cardiovascular events(MACEs)

    MACEs is a composite end point including cardiac death, non fatal myocardial infarction and target vessel revascularization(TVR).

    Measured: Within 1 year after PCI

  2. PCI related complication

    PCI related complication include coronary dissection, coronary perforation, device dislodgement, device entrapment and device rupture.

    Measured: Immediately after PCI

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jun 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionSep 2016 (estimated)
  4. Study completionSep 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
410 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02167230
Sponsor's protocol ID
JBT
Acronym
JBTinCBL
Status last verified
Jun 2014
First submitted
17 Jun 2014
Last updated
19 Jun 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Sharma SK, Sweeny J, Kini AS. Coronary bifurcation lesions: a current update. Cardiol Clin. 2010 Feb;28(1):55-70. doi: 10.1016/j.ccl.2009.10.001.

    PubMed 19962049
  • Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? JACC Cardiovasc Interv. 2008 Jun;1(3):218-26. doi: 10.1016/j.jcin.2007.12.008.

    PubMed 19463303
  • Depta JP, Patel Y, Patel JS, Novak E, Yeung M, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions. Catheter Cardiovasc Interv. 2013 Nov 1;82(5):E637-46. doi: 10.1002/ccd.24778. Epub 2013 Jul 30.

    PubMed 23420654
  • Colombo F, Biondi-Zoccai G, Infantino V, Omede P, Moretti C, Sciuto F, Siliquini R, Chiado S, Trevi GP, Sheiban I. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol. 2009 Oct;64(5):583-8. doi: 10.2143/AC.64.5.2042686.

    PubMed 20058502
  • Singh J, Patel Y, Depta JP, Mathews SJ, Cyrus T, Zajarias A, Kurz HI, Lasala JM, Bach RG. A modified provisional stenting approach to coronary bifurcation lesions: clinical application of the "jailed-balloon technique". J Interv Cardiol. 2012 Jun;25(3):289-96. doi: 10.1111/j.1540-8183.2011.00716.x. Epub 2012 Feb 26.

    PubMed 22364484

Questions about this trial

What is this clinical trial studying?

A study testing Jailed-balloon technique and Jailed-wire technique in people with Coronary Artery Disease, run by Guangdong Provincial People's Hospital at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pengcheng He, Doctor (86-20-83827812 ext. 10580, he_peng_cheng@aliyun.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Side branch(SB) loss and PCI related myocardial infarction (time frame: Within 48 hours after PCI). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02167230, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in